新型抗高血压药物有效降低了黑人患者的血压。 New drug aprocitentan effectively lowers blood pressure in Black patients with resistant hypertension.

一项关于超高血压的新研究表明,Idorsia Ltd的药物Aprocitentan实际上降低了抗高血压黑人患者的血压并减少了蛋白质。 A new study in Hypertension shows that aprocitentan, a drug by Idorsia Ltd, effectively lowers blood pressure and reduces proteinuria in Black patients with resistant hypertension. 这种针对内分泌系统的治疗被认为既安全又清洁,甚至在慢性肾病患者中也是如此。 The treatment, which targets the endothelin system, was found to be safe and well-tolerated, even in those with chronic kidney disease. 这一突破可以大大有助于管理黑人患者的抗性高血压,减少其心血管风险。 This breakthrough could significantly help manage resistant hypertension in Black patients, reducing their cardiovascular risks.